The Cochrane Collaboration
Cochrane Reviews
Explore New + Updated Other languages
Full Text:  The Cochrane Library
search & browse | by topic | full list of all reviews | by country of author | by date range

by Topic (Review Group):
Visit the "Schizophrenia Group" website here

Browse by topic (Review Group) - For sub-topics (only reviews + protocols), click here


View stages (what is this?): all titles Titles protocol Protocols review Reviews

Acetophenazine for schizophrenia (title stage)
Acupuncture for schizophrenia
Advance treatment directives for people with severe mental illness (protocol stage)
Amisulpride for schizophrenia
Amisulpride versus other atypical antipsychotics for schizophrenia (protocol stage)
Amphetamines for schizophrenia
Anticholinergic medication for neuroleptic-induced tardive dyskinesia
Anticholinergics for neuroleptic-induced acute akathisia
Anticholinergics for neuroleptic-induced parkinsonism (protocol stage)
Antidepressants for people with both schizophrenia and depression
Antidepressants for the negative symptoms of schizophrenia
Antiglucocorticoid and related treatments for psychosis (protocol stage)
Antipsychotic combinations for schizophrenia (protocol stage)
Antipsychotic drug treatment for elderly people with late-onset schizophrenia
Antipsychotic drugs for non-affective psychosis during pregnancy and postpartum
Antipsychotic medication for childhood-onset schizophrenia
Antipsychotic medication for early episode schizophrenia (protocol stage)
Antipsychotic medication for elderly people with schizophrenia
Antipsychotic medication versus placebo for people with both schizophrenia and learning disability
Antipsychotic switching for people with schizophrenia who have neuroleptic-induced weight or metabolic problems (protocol stage)
Aripiprazole for schizophrenia
Aripiprazole versus other atypical antipsychotics for schizophrenia (protocol stage)
Aripiprazole versus placebo for schizophrenia (protocol stage)
Updated
Aripiprazole versus typical antipsychotic drugs for schizophrenia
Art therapy for schizophrenia or schizophrenia-like illnesses
'As required' medication regimens for seriously mentally ill people in hospital
Assertive community treatment for people with severe mental disorders
Atypical antipsychotics for people with both schizophrenia and depression
Ayurvedic medicine for schizophrenia
Benperidol for schizophrenia
Benzodiazapines for catatonia in persons with schizophrenia and other serious mental illnesses (protocol stage)
Benzodiazepines alone or in combination with antipsychotic drugs for acute psychosis
Benzodiazepines for neuroleptic-induced acute akathisia
Benzodiazepines for neuroleptic-induced tardive dyskinesia
Benzodiazepines for schizophrenia
Beta-blocker supplementation of standard drug treatment for schizophrenia
Calcium channel blockers for neuroleptic-induced tardive dyskinesia
New
Cannabis and schizophrenia
Carbamazepine for schizophrenia
Case management for people with severe mental disorders
Central action beta-blockers versus placebo for neuroleptic-induced acute akathisia
Cessation of medication for people with schizophrenia already stable on chlorpromazine
Chinese herbal medicine for schizophrenia
Chlorpromazine for psychosis induced aggression or agitation (title stage)
Chlorpromazine versus atypical antipsychotics for schizophrenia (title stage)
Chlorpromazine versus placebo for schizophrenia
Cholinergic medication for neuroleptic-induced tardive dyskinesia
Clotiapine for acute psychotic illnesses
Clotiapine for schizophrenia (protocol stage)
Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia (protocol stage)
Clozapine versus other atypical antipsychotics for schizophrenia (protocol stage)
Clozapine versus other atypical antipsychotics for schizophrenia (title stage)
Clozapine versus typical neuroleptic medication for schizophrenia
Cognitive behaviour therapy for schizophrenia
Cognitive behaviour therapy versus psychosocio treatments for schizophrenia (title stage)
Cognitive behaviour therapy versus specific pharmacological treatments for schizophrenia (title stage)
Cognitive behaviour therapy versus standard care for schizophrenia (title stage)
Cognitive rehabilitation for people with schizophrenia and related conditions
Community mental health teams (CMHTs) for people with severe mental illnesses and disordered personality
Compliance therapy for schizophrenia
Compulsory community and involuntary outpatient treatment for people with severe mental disorders
Containment strategies for people with serious mental illness
Crisis intervention for people with severe mental illnesses
Dance therapy for schizophrenia (protocol stage)
Day centres for severe mental illness
Day hospital versus admission for acute psychiatric disorders
Day hospital versus out-patient care for psychiatric disorders
Depot bromperidol decanoate for schizophrenia
Depot flupenthixol decanoate for schizophrenia or other similar psychotic disorders
Depot fluphenazine decanoate and enanthate for schizophrenia
Depot fluspirilene for schizophrenia
Depot haloperidol decanoate for schizophrenia
Depot perphenazine decanoate and enanthate for schizophrenia
Depot pipotiazine palmitate and undecylenate for schizophrenia
Depot risperidone for schizophrenia
Distraction techniques for schizophrenia
Donezepil for schizophrenia (title stage)
Drama therapy for schizophrenia or schizophrenia-like illnesses
Droperidol for acute psychosis
Early Intervention for psychosis
Educational games for mental health professionals
Electroconvulsive therapy for schizophrenia
Estrogen for schizophrenia
Exercise therapy for schizophrenia (protocol stage)
Family intervention for schizophrenia
Gamma-aminobutyric acid agonists for neuroleptic-induced tardive dyskinesia
Glutamatergic drugs for schizophrenia
Haloperidol dose for the acute phase of schizophrenia
Updated
Haloperidol plus promethazine for psychosis-induced aggression
Haloperidol versus chlorpromazine for schizophrenia
Haloperidol versus placebo for schizophrenia
Hypnosis for schizophrenia
Immediate versus delayed treatment for psychosis (title stage)
Individual psychodynamic psychotherapy and psychoanalysis for schizophrenia and severe mental illness
Intensive Case Managment for severe mental illness (title stage)
Intercessory prayer for the alleviation of ill health
Intermittent drug techniques for schizophrenia (protocol stage)
Interventions for obsessive compulsive symptoms in people with schizophrenia (protocol stage)
Interventions for people with schizophrenia who commit arson (title stage)
Interventions for psychosis in adolescents (protocol stage)
Interventions to reduce weight gain in schizophrenia
Lamotrigine for schizophrenia
Length of hospitalisation for people with severe mental illness
Life skills programmes for chronic mental illnesses
Lithium for schizophrenia
Loxapine for schizophrenia
LY2140023 for schizophrenia (title stage)
Management of sexual dysfunction due to antipsychotic drug therapy
Miscellaneous treatments for neuroleptic-induced tardive dyskinesia
Molindone for schizophrenia and severe mental illness
Monetary incentives for schizophrenia (title stage)
Morita therapy for schizophrenia
Mother and baby units for schizophrenia
Music therapy for schizophrenia or schizophrenia-like illnesses
Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia
New generation antipsychotics for first episode schizophrenia
Newer atypical antipsychotic medication versus clozapine for schizophrenia
Nicotine for schizophrenia
Non-neuroleptic catecholaminergic drugs for neuroleptic-induced tardive dyskinesia
Olanzapine dose for schizophrenia (title stage)
Olanzapine for schizophrenia
Olanzapine IM or velotab for acutely disturbed/agitated people with suspected serious mental illnesses
Olanzapine versus other atypical antipsychotics for schizophrenia (protocol stage)
Olanzapine versus placebo for schizophrenia (title stage)
Olanzapine versus typicals for schizophrenia (title stage)
Open general medical wards versus specialist psychiatric units for acute psychoses
Oral flupenthixol for schizophrenia (title stage)
Oral fluphenazine versus placebo for schizophrenia
Outcome measures and needs assessment tools for schizophrenia and related disorders
Paliperidone for the treatment of adults with schizophrenia
Patient held clinical information for people with psychotic illnesses
Penfluridol for schizophrenia
Perazine for schizophrenia
Pericyazine for schizophrenia (title stage)
Perphenazine for schizophrenia
New
Pharmacological interventions for clozapine-induced hypersalivation
Pharmacological interventions for substance dependence in people with non-affective psychosis (title stage)
Pharmacological treatments for psychosis-related polydipsia
Pimozide for schizophrenia or related psychoses
Polyunsaturated fatty acid supplementation for schizophrenia
Problem solving skills for schizophrenia
Prompts to encourage appointment attendance for people with serious mental illness
Psychoeducation for schizophrenia
Psychosocial interventions for people with both severe mental illness and substance misuse
Quetiapine for schizophrenia
Quetiapine versus other atypical antipsychotics for schizophrenia (protocol stage)
New
Rehabilitation programmes for schizophrenia (protocol stage)
Residential alternatives to hospital admission for acute psychiatric disorders (title stage)
Risperidone versus olanzapine for schizophrenia
Risperidone versus other atypical antipsychotic medication for schizophrenia
Risperidone versus other atypical antipsychotics for schizophrenia (protocol stage)
Risperidone versus placebo for schizophrenia (protocol stage)
Risperidone versus typical antipsychotic medication for schizophrenia
Seclusion and restraint for people with serious mental illnesses
Sertindole for schizophrenia
Sertindole versus other atypical antipsychotics for schizophrenia (protocol stage)
Sertindole versus other atypicals for schizophrenia (title stage)
Social skills programmes for schizophrenia (title stage)
Sulpiride for schizophrenia
Sultopride for schizophrenia (protocol stage)
Supported housing for people with severe mental disorders
Supportive therapy for schizophrenia
Testosterone for schizophrenia
Thioridazine for schizophrenia
Token economy for schizophrenia
Training to recognise the early signs of recurrence in schizophrenia (protocol stage)
Transcranial magnetic stimulation for schizophrenia (protocol stage)
Treatment delivery using information and communication technology for people with schizophrenia (protocol stage)
Treatments for acute neuroleptic malignant syndrome (title stage)
Trifluoperazine for schizophrenia
Twenty-four hour care for schizophrenia (protocol stage)
Updated
Valproate for schizophrenia
Vitamin E for neuroleptic-induced tardive dyskinesia
Vocational rehabilitation for people with severe mental illness
Ziprasidone for schizophrenia and severe mental illness
Ziprasidone versus other atypical antipsychotics for schizophrenia (protocol stage)
Zotepine for schizophrenia
Zotepine versus other atypical antipsychotics for schizophrenia (protocol stage)
Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses
Zuclopenthixol decanoate for schizophrenia and other serious mental illnesses
Zuclopenthixol dihydrochloride for schizophrenia